Navigation Links


ID Global Solutions Corporation Becomes Ipsidy Inc.

2/7/2017
LONG BEACH, New York , February 7, 2017 Ipsidy Inc. ( www.ipsidy.com ), formerly known as ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or the "Company") a provider of secure, biometric identification, identity management and electronic transaction processing services, is pleased to announce the following changes as part of a reorganization of the Company. Effecti... [Comments]

Biometrics, Borders, and Extreme Vetting in the Age of Trump; More than 3500 Automated Border Control eGates and Kiosks Now Deployed Representing 37% CAGR in Three Years

2/6/2017
DENVER , Feb. 6, 2017 According to Acuity Market Intelligence, ongoing concerns about national security are driving border authorities to continue to embrace biometric and digital identification based automation. Acuity reports there are 2143 Automated Border Control (ABC) eGates and 1436 Automated Passport Control (APC) Kiosks currently deployed at more than 163 ports of entr... [Comments]

Texas Biomed Names Larry Schlesinger, M.D. As President/CEO

2/3/2017
SAN ANTONIO , Feb. 3, 2017  Texas Biomedical Research Institute announced that its Board of Trustees has named Dr. Larry Schlesinger as the Institute's new President and CEO. Dr. Schlesinger will take the helm of Texas Biomed effective May 31, 2017. He is currently the Chair of the Department of Microbial Infection and Immunity and Director of the Center for Microbial... [Comments]

Newly Launched Identity Strategy Partners, LLP Provides Policy and Technical Consultation on Complex Identity Issues to the Private and Public Sectors

2/3/2017
WASHINGTON , Feb. 3, 2017 A new independent identity strategy consultancy firm announces its formation, Identity Strategy Partners, LLP (IdSP) . Designed to fill a critical niche in technical and policy expertise in the complex identity market, founding partners Mark Crego and Janice Kephart together have nearly 35 combined years just in identity expertise that span feder... [Comments]

TapImmune Completes Scale-Up and GMP Manufacturing of TPIV 200 Vaccine to Supply Additional Phase 2 Clinical Trials

2/2/2017
JACKSONVILLE, Fla. , Feb. 2, 2017   TapImmune, Inc. (NASDAQ: TPIV ), a clinical-stage immuno-oncology company specializing in the development of innovative peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer and metastatic disease, announced today it has successfully completed a multi-gram scale-up and GMP manufacturing of a second clinica... [Comments]

EyeLock Releases New White Paper "What You Should Know About Biometrics in the Cloud"

2/2/2017
NEW YORK , Feb. 2, 2017  EyeLock LLC, a market leader of iris-based identity authentication solutions, has released a new white paper " What You Should Know About Biometrics in the Cloud ."  The problem of ensuring user authenticity is a growing concern. In traditional schemes, cryptography is used to protect the authentication of users. However, traditional authent... [Comments]

2017 Japan Prize Honors Trailblazers in Life Science and Cryptography

2/2/2017
TOKYO , Feb. 1, 2017  Central to its deep commitment to honor the most innovative and meaningful advances worldwide, The Japan Prize Foundation today announced the laureates of the 2017 Japan Prize, who have pushed the envelope in their respective fields of Life Sciences and Electronics, Information and Communication. Three scientists are being recognized with the 2017 Jap... [Comments]

IDTechEx Research Announces New Report on Sensors for Robotics

2/1/2017
BOSTON, Massachusetts , February 1, 2017 IDTechEx Research, a leading provider of independent market research, business intelligence and events on emerging technology, announces the availability of a new report, Sensors for Robotics: Technologies, Markets and Forecasts 2017-2027 . Continue Reading Revenues of vision systems in industri... [Comments]

Spero Therapeutics Acquires Next Generation Antibacterial Candidates from Pro Bono Bio for Treatment of Multidrug-Resistant, Gram-Negative Infections

1/31/2017
CAMBRIDGE, Mass. , Jan. 31, 2017  Spero Therapeutics, LLC, a biopharmaceutical company founded to develop novel therapies for the treatment of bacterial infections, today announced it has acquired a next generation set of antibacterial candidates from Pro Bono Bio Ltd (PBB) to bolster its pipeline addressing the increased prevalence of multi-drug resistant forms... [Comments]

Invitae to announce fourth quarter and year-end 2016 financial results and 2017 guidance and will host conference call on February 13, 2017

1/30/2017
SAN FRANCISCO , Jan. 30, 2017   Invitae Corporation (NYSE: NVTA ), one of the fastest growing genetic information companies, today announced that it will report its fourth quarter and year-end 2016 financial results and provide 2017 guidance on Monday, February 13, 2017, and Invitae's management team will host a conference call that day at 4:45 p.m. Eastern / 1:45 p.m.... [Comments]

[previous] [next]
(Date:2/16/2017)... 2017  Genos, a community for personal genetic ... received Laboratory Accreditation from the College of American ... laboratories that meet stringent requirements around quality, accuracy ... "Genos is committed to maintaining the ... honored to be receiving CAP accreditation," said ...
(Date:2/13/2017)... , Feb. 13, 2017 Former 9/11 ... Senate Judiciary Committee, Janice Kephart of Identity ... President Donald Trump,s "Executive Order: Protecting the ... (Jan. 27, 2017):  "As President Trump,s ,Travel ... Circuit has now essentially banned the travel ban, it ...
(Date:2/8/2017)... 2017 About Voice Recognition Biometrics Voice recognition ... against a stored voiceprint template. Acoustic features of ... tone are compared to distinguish between individual voices. ... most PCs already have a microphone and can ... biometrics are most likely to be deployed in ...
Breaking Biology News(10 mins):
ANTI ALPHA FSH:B...
... Serum-Mixed Breed • Dog serum is collected from ... year of age Available Anticoagulants: ... N-06: K2EDTA N-08: Potassium ... Alsevers N-05: ACD N-07: ...
MOUSE ANTI BOVINE TROPONIN I...
NORMAL DONOR DONKEY SERUM...
Biology Products:
(Date:2/27/2017)... , Feb. 27, 2017 /PRNewswire/ - InMed Pharmaceuticals, Inc. ("InMed") ... expiry on Friday, February 24, 2017 a total of 10,672,750 ... of $0.13 per common share. Proceeds from the exercise of ... from InMed,s Treasury.   ... "We are grateful for this expression of confidence ...
(Date:2/27/2017)... 27, 2017 Fluxion Biosciences announced today that ... has been appointed as a Certified Service Provider for ... will be used in Genetracer Biotech,s novel liquid biopsy ... colon cancer, with plans to move to other cancers ... Fluxion,s IsoFlux System to isolate, recover, and analyze CTCs ...
(Date:2/25/2017)... ... February 25, 2017 , ... The ... in an ongoing effort to create meaningful change by increasing communication, partnerships and ... emphasis on consumers and patients’ mental health well-being. , Both organizations are dedicated ...
(Date:2/24/2017)... , Feb. 24, 2017 Provectus ... or the "Company"), a clinical-stage oncology and dermatology ... the deadline to participate in its previously announced ... consisting of shares of common stock and Series ... holders of listed warrants. As ...
Breaking Biology Technology: